Contrast Media/Contrast Agents Market Revenue Drivers, Growth Opportunities, Supply Chain Analysis and Forecast Research Report Till 2025
“The global Contrast Media/Contrast Agents market was valued at USD 4.25 Billion in 2016 and is expected to register a CAGR of 3.8% in the forecast period.”
The global Contrast Media/Contrast Agents Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development. Market Overview: The global Contrast Media/Contrast Agents market was valued at USD 4.25 Billion in 2016 and is expected to register a CAGR of 3.8% in the forecast period. The market is driven by factors such as rise in number of testing centers coupled with rise in number of government approvals for contrast agents. Increasing cases of cancer and rise in R&D activities add to the market growth in the forecast period. However, side effects and adverse reactions on health by use of Contrast Media/Contrast Agents are expected to restrict the market growth during the forecast period. Contrast Media market is segmented based on agent type, modality, application, and region. Type category for the market includes barium based, gadolinium-based, microbubble and iodinated. Key Players:
Bayer AG General Electric Company Guerbet Lantheus Medical Imaging, Inc. Bracco Diagnostics, Inc.